A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients.
G
G
Woodrow
D015314:Dialysis Solutions / Q000737:chemistry* / Q000627:therapeutic use*; D017127:Glycation End Products, Advanced / Q000032:analysis*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D010530:Peritoneal Dialysis; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D016896:Treatment Outcome
D015314:Dialysis Solutions; D017127:Glycation End Products, Advanced